Modeling Composite Assessment Data Using Item Response Theory-Reference-Cited by-同舟云学术

Modeling Composite Assessment Data Using Item Response Theory

Published:2018-03 Issue:4 Volume:7 Page:205-218
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacometrics Syst. Pharmacol.

Author:

Ueckert Sebastian¹

Affiliation:

1. Pharmacometrics Research Group, Uppsala University Sweden

Publisher

Wiley

Subject

Pharmacology (medical),Modelling and Simulation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12280

Reference41 articles.

1. The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity

2. The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia

3. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

4. A Brief History of Item Theory Response

5. Lazarsfeld P.The logical and mathematical foundation of latent structure analysis. 362–412 In:Measurement andprediction. Vol. 4 of Studies in Social Psychology in World War II. (Princeton University Press Princeton NJ 1950).

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling of Parkinson’s Disease Progression and Implications for Detection of Disease Modification in Treatment Trials;Journal of Parkinson's Disease;2024-09-03

2. Sparse item testing of clinical scales in neurology trials to alleviate burden to patients;Journal of Neurology;2024-08-30

3. Item Response Theory Quantifies the Relationship Between Improvements in Serum Phosphate and Patient‐Reported Outcomes in Adults With X‐Linked Hypophosphatemia;Clinical Pharmacology & Therapeutics;2024-08-12

4. Item performance of the scale for the assessment and rating of ataxia in rare and ultra‐rare genetic ataxias;CPT: Pharmacometrics & Systems Pharmacology;2024-05-21

5. Model‐Informed Assessment of Probability of Phase 3 Success for Ritlecitinib in Patients with Moderate‐to‐Severe Ulcerative Colitis;Clinical Pharmacology & Therapeutics;2024-04-16